JALYN WALL: Open Payments
NPI 1073579454 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 56 payments from 16 companies in 2025. Trend: 2023 $2,318 · 2024 $1,346 · 2025 $1,516
Food & beverage: $1,484Education: $32
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $438 |
| Novo Nordisk Inc | 13 | $217 |
| Lilly USA, LLC | 8 | $151 |
| ABBVIE INC. | 7 | $145 |
| Astellas Pharma US Inc | 5 | $125 |
| Axsome Therapeutics, Inc. | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| PFIZER INC. | 4 | $69 |
| Boston Scientific Corporation | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: FREESTYLE LIBRE 3, Veozah, VRAYLAR, MOUNJARO, Auvelity, PREVNAR 20, AIRSUPRA, Wegovy.
Industry payments across TX — which companies pay providers there.
